Quantitative Benefit-Risk Analysis of Medical Radiation Exposures

被引:17
|
作者
Zanzonico, Pat [1 ]
Stabin, Michael G. [2 ]
机构
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA
[2] Vanderbilt Univ, Dept Radiol & Radiol Sci, Nashville, TN 37235 USA
关键词
COMPUTED-TOMOGRAPHY; CANCER; ANGIOGRAPHY; PREGNANCY;
D O I
10.1053/j.semnuclmed.2014.03.010
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
While it is commonly said that the benefits of the use of radiation in the healing arts far outweigh any potential risks, there has not been to date an attempt to quantify the numerical benefits of uses of medical radiation. Using the 'Linear, No-Threshold' (LNT) model of radiation carcinogenesis, many have provided numerical estimates of the risks of radiation exposure, sometimes in irresponsible ways. In this work, we show, through several selected examples, how the numerical benefits of medical radiation exposures indeed far outweigh any theoretical cancer risks. Choosing more invasive measures, there are known rates of complications that result in mortalities in the patient populations. We note these real risks in the selected examples and compare them to the theoretical risks of cancer predicted by the LNT model. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:210 / 214
页数:5
相关论文
共 50 条
  • [1] A RADIATION BENEFIT-RISK ANALYSIS OF MAMMOGRAPHY
    JAYARAMAN, S
    AGARWAL, SK
    READ, M
    BHADURI, D
    [J]. MEDICAL PHYSICS, 1981, 8 (04) : 575 - 575
  • [2] Quantitative Benefit-Risk Analysis for Evaluating Drug Therapies
    Kodell, Ralph L.
    Chen, James J.
    [J]. JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2013, 23 (01) : 231 - 238
  • [3] Benefit-risk analysis: examples using quantitative methods
    Holden, WL
    Juhaeri, J
    Dai, WJ
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2003, 12 (08) : 693 - 697
  • [4] Benefit-risk analysis: a proposal using quantitative methods
    Holden, WL
    Juhaeri, J
    Dai, WJ
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2003, 12 (07) : 611 - 616
  • [5] THE NEGLECTED SIDE OF THE COIN: QUANTITATIVE BENEFIT-RISK ANALYSES IN MEDICAL IMAGING
    Zanzonico, Pat B.
    [J]. HEALTH PHYSICS, 2016, 110 (03): : 301 - 304
  • [6] Benefit-risk analysis - A brief review and proposed quantitative approaches
    Holden, WL
    [J]. DRUG SAFETY, 2003, 26 (12) : 853 - 862
  • [7] A new framework to address challenges in quantitative benefit-risk assessment for medical products
    Fu, Bo
    Li, Xuefeng
    Scott, John
    He, Weili
    [J]. CONTEMPORARY CLINICAL TRIALS, 2020, 95
  • [8] On a Stepwise Quantitative Approach for Benefit-Risk Assessment
    He, Weili
    Sun, Yaxuan
    Li, Qing
    Wan, Sabrina
    [J]. THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2017, 51 (05) : 625 - 634
  • [9] On a Stepwise Quantitative Approach for Benefit-Risk Assessment
    Weili He
    Yaxuan Sun
    Qing Li
    Sabrina Wan
    [J]. Therapeutic Innovation & Regulatory Science, 2017, 51 : 625 - 634
  • [10] Structured benefit-risk evaluation for medicinal products: review of quantitative benefit-risk assessment findings in the literature
    Kurzinger, Marie-Laure
    Douarin, Ludivine
    Uzun, Ievgeniia
    El-Haddad, Chantal
    Hurst, William
    Juhaeri, Juhaeri
    Tcherny-Lessenot, Stephanie
    [J]. THERAPEUTIC ADVANCES IN DRUG SAFETY, 2020, 11